News & Publications
content-image
 Qureator’s Historic FDA IND Approval Based on Human-Relevant Data Highlighted in The BIO
November 25, 2025
|
Tags : Press highlights ,
content-image
 Qureator Achieves World’s First FDA IND Approval Using Only Human Vascularized Organoid Efficacy Data
October 27, 2025
|
Tags : Press highlights , Spotlight ,
content-image
 Qureator’s Collaboration Highlighted in Korean Economic Daily
March 18, 2025
|
Tags : Press highlights ,
Select Category
AllActivitiesPress highlightsSpotlight
TTK/PLK1 dual antagonist BAL0891 synergizes with pembrolizumab in a vascularized 3D tumor microenvironment model
August 15, 2025
|
Tags :
Profiling patient response to TTK/PLK1 dual antagonist BAL0891 using 3D patient-derived organoid model in a microphysiological system
August 15, 2025
|
Tags :
Discovery of potential synergistic targets for PKMYT1 inhibitor through AI-assisted drug combination screening in an MPS-based vascularized metastatic gastric cancer model
April 15, 2025
|
Tags :
A High-Throughput Microphysiological Liver Chip System to Model Drug-Induced Liver Injury Using Human Liver Organoids
August 6, 2024
|
Tags :
High-Throughput Microfluidic 3D Outer Blood-Retinal Barrier Model in a 96-Well Format: Analysis of Cellular Interactions and Barrier Function in Retinal Health and Disease
July 12, 2024
|
Tags :
Engineering a perfusable vascularized tumor immune microenvironment using microphysiological system
April 18, 2024
|
Tags :
Development of an in vitro gastric cancer 3D co-culture platform using a microphysiological system (MPS) to improve outcomes in oncology clinical trials
March 22, 2024
|
Tags :
High-throughput Microfluidic 3D Outer Blood-Retinal Barrier Model in a 96-Well Format: Analysis of Cellular Interactions and Barrier Function in Retinal Health and Disease
February 1, 2024
|
Tags :
A High-Throughput Microphysiological Liver Chip System to Model Direct and Idiosyncratic Drug-Induced Liver Injury Using Human Liver Organoids
December 4, 2023
|
Tags :
Load More